tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
AptarGroup’s Resilience and Strategic Focus Drive Buy Rating Despite Mixed Results
PremiumRatingsAptarGroup’s Resilience and Strategic Focus Drive Buy Rating Despite Mixed Results
18d ago
AptarGroup reports Q3 EPS $1.62, consensus $1.57
Premium
The Fly
AptarGroup reports Q3 EPS $1.62, consensus $1.57
18d ago
AptarGroup sees Q4 adjusted EPS $1.20-$1.28, consensus $1.44
Premium
The Fly
AptarGroup sees Q4 adjusted EPS $1.20-$1.28, consensus $1.44
18d ago
Nasus Pharma announces expanded agreement to support NS002
PremiumThe FlyNasus Pharma announces expanded agreement to support NS002
1M ago
AptarGroup’s Strategic Shift to Pharma Drives Buy Rating Amid Profitability Gains
Premium
Ratings
AptarGroup’s Strategic Shift to Pharma Drives Buy Rating Amid Profitability Gains
2M ago
AptarGroup price target lowered to $152 from $153 at Wells Fargo
Premium
The Fly
AptarGroup price target lowered to $152 from $153 at Wells Fargo
2M ago
AptarGroup price target lowered to $172 from $182 at Raymond James
PremiumThe FlyAptarGroup price target lowered to $172 from $182 at Raymond James
4M ago
AptarGroup price target lowered to $153 from $173 at Wells Fargo
Premium
The Fly
AptarGroup price target lowered to $153 from $173 at Wells Fargo
4M ago
AptarGroup Reports Strong Q2 2025 Results
Premium
Company Announcements
AptarGroup Reports Strong Q2 2025 Results
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100